Skip to main content
Signal8

Truitt Joseph

SEC insider (Form 3/4/5 filer). CIK 0001452429. Director at Century Therapeutics, Inc. (IPSC) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Sep 9, 2026. Located in PHILADELPHIA, PA.

Companies Truitt Joseph has filed insider reports for

  • Century Therapeutics, Inc. (IPSC): Director
  • Larimar Therapeutics, Inc. (LRMR): Director
Truitt Joseph profile photo

Truitt Joseph

CIK: 0001452429

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Century Therapeutics, Inc. logo
IPSC

Century Therapeutics, Inc.

Director
Larimar Therapeutics, Inc. logo
LRMR

Larimar Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Century Therapeutics, Inc. logo
    IPSC

    Century Therapeutics, Inc.

    Sep 9, 2026
    Award

    Stock Option (right to buy)

    Direct
    148K shares-
  • Larimar Therapeutics, Inc. logo
    LRMR

    Larimar Therapeutics, Inc.

    May 19, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    55.2K shares-
  • Larimar Therapeutics, Inc. logo
    LRMR

    Larimar Therapeutics, Inc.

    May 13, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    19K shares-

1-3 of 3